(Q37956376)

25 August 2017

title

Rotarix®: vaccine performance 6 years postlicensure (English)

1 reference

25 August 2017

Yalda Lucero

2

0 references

author name string

Miguel O'Ryan

series ordinal

1

1 reference

25 August 2017

Alexandre C Linhares

series ordinal

3

1 reference

25 August 2017

publication date

1 December 2011

1 reference

Expert Review of Vaccines

25 August 2017

published in

1 reference

25 August 2017

volume

10

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

1645-1659

1 reference

Update on Rotarix: an oral human rotavirus vaccine

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Chronic suppurative otitis media in a birth cohort of children in Greenland: population-based study of incidence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Real-world impact of rotavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Rotavirus vaccine introduction in the Americas: progress and lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Global impact of rotavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Rotavirus vaccines in Belgium: policy and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Intussusception among infants given an oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

The ever-changing landscape of rotavirus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Rotavirus disease and vaccination: impact on genotype diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Effect of rotavirus vaccination on circulating virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Group A rotavirus genotypes and the ongoing Brazilian experience: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Molecular epidemiology of group A rotavirus in Buenos Aires, Argentina 2004-2007: reemergence of G2P[4] and emergence of G9P[8] strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Analysis of porcine circovirus type 1 detected in Rotarix vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.152

21 January 2018

Identifiers

DOI

10.1586/ERV.11.152

1 reference

release_4rggz2bedva5flzh24udn7m7fy

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4rggz2bedva5flzh24udn7m7fy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference